Expression of MAGE-1, MAGE-2 and MAGE-3 genes in human gastric carcinomas; lack of evidence for cytotoxic effects in cases with simultaneous expression of MAGE-3 and HLA-A2

Anticancer Research

Volumn 18, Issue 5 B, 1998, Pages 3639-3644

  Ofuji, Satoshi ^a   Ikeda, Mitsuyuki ^a   Tsujitani, Shunichi ^a   Ikeguchi, Masahide ^a   Kaibara, Nobuaki ^a   Yuasa, Isao ^b   Mitsuya, Kohzoh ^a   Katoh, Motonobu ^a   Ito, Hisao ^a,b  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

HLA A2 apoptosis gastric carcinoma; MAGE

Indexed keywords

HLA A2 ANTIGEN; KI 67 ANTIGEN; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; INTESTINE METAPLASIA; INTESTINE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; STOMACH MUCOSA; SURVIVAL RATE;

ANTIGENS, NEOPLASM; APOPTOSIS; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NEOPLASM PROTEINS; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0031673071     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Van Der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van Den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647, 1991.
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, Van Der Bruggen P, Lethé B, Lurquin C, Brasseur K, Chomez P, De Backer O, Cavenee W and Boon T: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetic 40: 360-369, 1994.
3. Inoue H, Mori M, Honda M, Li J, Shibuta K, Mimori K, Ueo H, and Akiyoshi T: The expression of tumor-rejection antigen "MAGE" genes in human gastric carcinoma. Gastrenterology 109: 1522-1525, 1995.
4. Traversari C, Van Der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, and Boon T: A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176: 1453-1457, 1992.
5. Van Der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A. and Boon T: A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur J Immunol 24: 3038-3043, 1994.
6. Dong R, Kimura A, Okubo R, Shinagawa H, Tamai H, Nishimura Y and Sasazuki T: HLA-A and DPB1 loci confer susceptibility to Graves' disease. Hum Immunol 35: 165-172, 1992.
7. Yashiro M, Chung YS, Nishimura S, Inoue T and Sowa M: Estabishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. Brit J Cancer 72: 1200-1210, 1995.
8. Sekiguchi M, Sakakibara K and Fujii G: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 48: 61-68, 1978.
9. Ochiai A, Takanashi A, Takekura N, Yoshida K, Miyamori S, Harada T and Tahara E: Effect of human epidermal growth factor on cell growth and its receptor in human gastric carcinoma cell lines. Jpn J Clin Oncol 18: 15-25, 1988.
10. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
11. Weynants P, Lethe B, Brasseur F, Marchand M and Boon T: Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 56: 826-829, 1994.
12. Brasseur F, Marchand M, Vanwijck R, Herin M, Lethé B, Chomez P, and Boon T: Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors. Int J Cancer 52: 839-841, 1992.
13. De Smet C, Lurquin C, Van Der Bruggen P, De Plaen E, Brasseur F and Boon T: Sequence and expression pattern of the human MAGE-2 gene. Immunogenetics 39: 121-129, 1994.
14. Gaugler B, Van Den Eynde B, Van Der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, and Boon T: Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179: 921-930, 1994.
15. Fernandez-Viña MA, Falco M, Sun Y and Stastny P: DNA typing for HLA class I alleles: I. subsets of HLA-A2 and of-A28. Hum Immunol 33: 163-173, 1992.
16. Zemmour J and Parham P: HLA class 1 nucleotide sequences, 1991. Hum Immunol 31: 195-206, 1991.
17. Ton Y, Yamana H, Shichijo S, Fujita H, Tou U, Sakaguchi M, Kakegawa T and Itoh K: Expression of MAGE-1 gene by esophageal carcinomas. Jpn J Cancer Res 86: 714-717, 1995.
18. Lewis FA, Griffiths S, Dunicliffe R, Wells M, Dudding N and Bird CC: Sensitive in-situ hybridization technique using biotin streptavidin polyalkaline phosphatase complex. J Clin Pathol 40: 163-166, 1987.
19. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64: 31-49, 1965.
20. Li J, Yang Y, Fujie T, Baba K, Ueo H, Mori M and Akiyoshi T: Expression of BAGE, GAGE, and MAGE genes in human gastric carcinoma. Clin Cancer Res 2: 1619-1625, 1996.
21. Gomyo Y, Osaki M, Kaibara N and Ito H: Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP. Int J Cancer 66: 594-599, 1996.
22. Ochiai A, Yamauchi Y and Hirohashi S: p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer (Pred. Oncol.) 69: 28-33, 1996.
23. Becker JC, Gillitzer R and Bröcker EB: A member of the melanoma antigen-encoding gene (MAGE) family is expressed in human skin during wound healing. Int J Cancer 58: 346-348, 1994.
24. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J and Rosenberg SA: Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-Aza-2′-Deoxycytidine. Cancer Res 54: 1766-1771, 1994.
25. Serrano A, García A, Abril E, Garrido F and Ruiz-Cabello F: Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int J Cancer 68: 464-470, 1996.
26. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH and Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987, 1994.
27. Kägi D, Vignaux F, Ledermann B, Bürki K, Depraetere V, Nagata S, Hengartner H and Golstein P: Fas and perform pathways as major mechanisms of T-cell mediated cytotoxicity. Science 265: 528-530, 1994.
28. Marchand M and 20 others: Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 63: 883-885. 1995.
29. Van Den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S and Boon T: A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182: 689-698, 1995.